The recent announcements were made possible due to agreements reached with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk, makers of the popular GLP-1 medications
Consider this your Lemonade moment: sustainable, nutritionally complete, and absolutely worth the hype
Food and Drug Administration (FDA) to treat obesity, expanding their use beyond the original purpose of diabetes management, demand for these drugs is skyrocketing and employers are struggling to weigh the high costs of coverage
Its also useful in patients focused on resilience, lowering inflammation, and recovery rather than purely cosmetic outcomes
Start your intake How Semaglutide Works in the Body Semaglutide activates GLP-1 receptors in the brain's appetite centers and slows stomach emptying, which is why it's effective for weight loss in people with obesity